|
0
|
|
UpTCR: a unified progressive knowledge transfer foundation model for robust T-cell receptor-antigen binding recognition.
(nature.com)
|
Lv T
…
Pan X
Nature Communications
2026-09-24
|
#immunotherapy
#t cell
#binding
#neoantigens
#machine learning
|
|
0
|
|
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.
(science.org)
|
Hinterleitner C
…
Lowe SW
Science
2026-09-24
|
#senescence
#fibrosis
#nanotherapy
#cancer
#immunotherapy
|
|
0
|
|
Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial.
(nature.com)
|
Shitara K
…
Lee KW
Nature Medicine
2026-09-24
|
#clinical trial
#immunotherapy
#gastric cancer
#her2
#combination therapy
|
|
0
|
|
Human-centric preclinical models for CAR T cell therapy in solid tumors: Where patient-derived organoids fit.
(linkinghub.elsevier.com)
|
Ma X
…
Brown CE
Cancer Cell
2026-09-24
|
#cancer
#immunotherapy
#organoid
#preclinical
#amr
|
|
0
|
|
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma.
(nejm.org)
|
Frigault MJ
…
Bishop MR
New England Journal of Medicine
2026-09-24
|
#car-t
#myeloma
#immunotherapy
#cytotoxicity
|
|
0
|
|
Increased extracellular fluid viscosity drives M2-like macrophage polarization to promote breast cancer progression and immunotherapy resistance.
(linkinghub.elsevier.com)
|
Zhang J
…
Xu F
Cell Reports
2026-09-24
|
#immunotherapy
#macrophage
#breast cancer
#immunosuppression
#mechanotransduction
|
|
0
|
|
Follistatin drives AR-independent prostate cancer through BMP signaling inactivation and microenvironmental remodeling.
(pnas.org)
|
Shi X
…
Su W
PNAS
2026-09-24
|
#prostate cancer
#drug resistance
#immunotherapy
#signaling
#tumor microenvironment
|
|
0
|
|
AIM2 in tregs restrains anti-PD-1 efficacy by reinforcing immune suppression in MC38 colorectal cancer.
(linkinghub.elsevier.com)
|
Wang N
…
Zheng X
iScience
2026-09-24
|
#cancer
#immunotherapy
#immunosuppression
#immunity
#checkpoint
|